DK0551449T3 - Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus - Google Patents

Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus

Info

Publication number
DK0551449T3
DK0551449T3 DK92907669T DK92907669T DK0551449T3 DK 0551449 T3 DK0551449 T3 DK 0551449T3 DK 92907669 T DK92907669 T DK 92907669T DK 92907669 T DK92907669 T DK 92907669T DK 0551449 T3 DK0551449 T3 DK 0551449T3
Authority
DK
Denmark
Prior art keywords
ppv
porcine parvovirus
capsides
subunit vaccine
protein
Prior art date
Application number
DK92907669T
Other languages
Danish (da)
English (en)
Inventor
Alvarez Jose Ignacio Casal
Valdes Elena Cortes
Kristian Dalsgaard
Casares Ana Isabel Ranz
Olmo Carmen Vela
Original Assignee
Inmunologia & Genetica Aplic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia & Genetica Aplic filed Critical Inmunologia & Genetica Aplic
Application granted granted Critical
Publication of DK0551449T3 publication Critical patent/DK0551449T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92907669T 1991-03-26 1992-03-26 Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus DK0551449T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100845A ES2026827A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
PCT/ES1992/000032 WO1992017589A1 (fr) 1991-03-26 1992-03-26 Procede de production d'un vaccin sous-unitaire contre le parvovirus porcin

Publications (1)

Publication Number Publication Date
DK0551449T3 true DK0551449T3 (da) 1998-07-20

Family

ID=8271931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92907669T DK0551449T3 (da) 1991-03-26 1992-03-26 Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus

Country Status (8)

Country Link
US (1) US5498413A (fr)
EP (1) EP0551449B1 (fr)
AT (1) ATE159547T1 (fr)
AU (1) AU1537792A (fr)
DE (1) DE69222840T2 (fr)
DK (1) DK0551449T3 (fr)
ES (1) ES2026827A6 (fr)
WO (1) WO1992017589A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113572A1 (fr) * 1991-07-17 1993-02-04 Peter J. Walker Vaccin ameliore
CA2132742C (fr) * 1993-01-23 2000-04-18 Carmen Vela Olmo Peptides synthetiques et vaccins contre les parvovirus
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
EP0914440B1 (fr) * 1996-04-19 2007-01-10 Merial Ltd. Vaccination avec des acides nucleiques contre les infections parvovirales
CA2223029A1 (fr) * 1997-02-12 1998-08-12 Akzo Nobel Nv Vaccins a adn contre des parvovirus canins
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) * 1997-12-11 2006-07-12 ユニバーシティ オブ サスカッチェワン ブタからの離乳後多全身系消耗症候群ウイルス
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
ES2139537B1 (es) * 1998-03-24 2000-10-01 Inmunologia & Genetica Aplic Sistema de presentacion de antigenos basado en el virus de la sharka.
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
SE516522C2 (sv) 1999-05-28 2002-01-22 Anoto Ab Positionsbestämning
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
JP2003526377A (ja) * 2000-03-14 2003-09-09 ニユーロロジクス・インコーポレーテツド キメラキャプシドベクターの製造
WO2001094392A2 (fr) * 2000-06-05 2001-12-13 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri Food Canada Sous-unites de proteines recombinantes produites dans des plantes a partir d'un parvovirus porcin
PL2275132T3 (pl) * 2005-12-29 2021-09-13 Boehringer Ingelheim Animal Health USA Inc. Multiwalentne immunogenne kompozycje PCV2 i sposoby ich wytwarzania
CN101851609B (zh) * 2010-02-02 2012-10-03 哈药集团生物疫苗有限公司 猪细小病毒l株及在制备猪细小病毒病灭活疫苗中的用途
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
DK3534939T3 (da) 2016-11-03 2023-04-24 Boehringer Ingelheim Vetmedica Gmbh Vaccine mod porcin parvovirus og porcin reproduktions- og respirationssyndromvirus og fremgangsmåder til fremstilling deraf
MY191490A (en) 2016-11-03 2022-06-28 Boehringer Ingelheim Vetmedica Gmbh Vaccine against porcine parvovirus
KR102117811B1 (ko) * 2018-12-05 2020-06-02 대한민국(농림축산식품부 농림축산검역본부장) 재조합 돼지파보바이러스 항원 단백질 및 이의 용도
US11701419B2 (en) 2019-04-04 2023-07-18 Boehringer Ingelheim Animal Health USA Inc. Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
CN110845580A (zh) * 2019-11-05 2020-02-28 中国农业科学院兰州兽医研究所 一种猪细小病毒样颗粒的组装及其免疫原性鉴定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117767A1 (fr) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Préparation des unités secondaires des vaccins de parvovirus
WO1988002026A1 (fr) * 1986-09-08 1988-03-24 Applied Biotechnology, Inc. Vaccins de capsides viraux vides
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
DD286820A5 (de) * 1989-08-10 1991-02-07 Univ Berlin Humboldt Verfahren zur herstellung des rekombinanten proteins hbcag delta-hivp24, das eine fusion aus den coreproteinen von hepatitis b-virus und humahem immundefizienzvirus 1 darstellt

Also Published As

Publication number Publication date
DE69222840D1 (de) 1997-11-27
ES2026827A6 (es) 1992-05-01
ATE159547T1 (de) 1997-11-15
DE69222840T2 (de) 1998-05-14
WO1992017589A1 (fr) 1992-10-15
EP0551449B1 (fr) 1997-10-22
US5498413A (en) 1996-03-12
AU1537792A (en) 1992-11-02
EP0551449A1 (fr) 1993-07-21

Similar Documents

Publication Publication Date Title
DK0551449T3 (da) Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus
AU1585092A (en) Method for producing a subunit vaccine against the canine parvovirus and other related viruses
Fiore et al. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin
NO871313L (no) Fremgangsmaate for fremstilling av virusvaksine.
Fang et al. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus
Tosser et al. Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses
DK1033995T3 (da) Hele eller sprængte insektceller som adjuvans for antigener
ATE302795T1 (de) Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus hüllproteine
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
NO904806D0 (no) Rekombinante flagellin-vaksiner.
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
Chen et al. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine
WO1998055626A3 (fr) Virus du syndrome dysgenesique respiratoire porcin recombine destine a etre utilise comme vaccin
Urasawa et al. Nucleotide sequence of VP4 and VP7 genes of a unique human rotavirus strain Mc35 with subgroup I and serotype 10 specificity
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
Hoshino et al. Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests
Huang et al. Comparative sequence analysis of VP4s from five Australian porcine rotaviruses: implication of an apparent new P type
JP2009544303A5 (fr)
RU2006106427A (ru) Вакцина
Vakharia Development of recombinant vaccines against infectious bursal disease
Ito et al. Sequence analysis of the VP6 gene in group A turkey and chicken rotaviruses
MX2022007217A (es) Vacuna epitópica para virus de fiebre porcina africana.
WO2004032622A3 (fr) Production de peptides dans des plantes sous forme d'hybride de proteines de coque virale
Grigera et al. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.